Colorectal Neoplasms
633
72
96
295
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
77 trials with published results (12%)
Research Maturity
295 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.2%
58 terminated out of 633 trials
83.6%
-2.9% vs benchmark
10%
66 trials in Phase 3/4
26%
77 of 295 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 295 completed trials
Clinical Trials (633)
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
Colorectal Adenoma Cohort
Real-time AI-assisted Endocyroscopy for the Diagnosis of Colorectal Lesions
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Comparison of the Left-Lateral Horizontal and Supine Positions for Colonoscopy Intervention: A Randomized Controlled Study
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
S0820, Adenoma and Second Primary Prevention Trial
Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy